US Bayer Chief Says Growth Must Double

27 November 1997

David Ebsworth, president of Bayer Pharmaceutical, the US subsidiary ofthe German group, has said that the company needs to increase its global US market share from 2.2% to 4% and grow significantly thereafter. The company, which has sales of $2.2 billion and employs some 6,500 people, is currently doubling its sales force to over 2,000.

- Meantime, Agfa, a US unit of Bayer, is to sue General Electric Co in an attempt to prevent a former employee from divulging medical-imaging trade secrets to GE, according to the Wall Street Journal. Through its suit in the federal district court in Chicago, Agfa is seeking a temporary restraining order to stop Vishal Wanchoo from using data to benefit GE's medical systems unit. A GE spokesman called the suit "meritless," and said GE is confident it will prevail in court.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight